Role of surgery and of radiotherapy in malignant pleural mesothelioma Source: ERS Online Course 2020: Calendar sheets in malignant pleural diseases Year: 2020
Is there any advantage of chemotherapy on survival of patients with diffuse malignant pleural mesothelioma? Source: Eur Respir J 2003; 22: Suppl. 45, 29s Year: 2003
Predictors of survival in patients undergoing radical surgery for malignant mesothelioma Source: Eur Respir J 2002; 20: Suppl. 38, 187s Year: 2002
PET predicts survival in malignant pleural mesothelioma Source: ISSN=ISSN 1810-6838, ISBN=, page=290 Year: 2007
Cisplatin/pemetrexed chemotherapy versus palliative care survival in malignant pleural mesothelioma Source: International Congress 2018 – Clinical management of pleural malignancies, including mesothelioma Year: 2018
Efficacy of pleurodesis for malignant pleural effusions in breast cancer patients Source: Eur Respir J 2011; 38: 1425-1430 Year: 2011
Treatment of malignant pleural mesothelioma with caelyx: few responses but good survival Source: Eur Respir J 2004; 24: Suppl. 48, 526s Year: 2004
Extrapleural pneumonectomy versus pleurectomy/decortication in malignant pleural mesothelioma: an updated meta-analysis of survival endpoints Source: International Congress 2019 – All aspects of general thoracic surgery Year: 2019
Survival time in patients with malignant pleural mesothelioma Source: Annual Congress 2007 - Rare tumours, risk factors and epidemiology in thoracic oncology Year: 2007
Three dimensional evaluation of chemotherapy response in malign pleural mesothelioma Source: Eur Respir J 2007; 30: Suppl. 51, 754s Year: 2007
Evaluation of chemotherapy response determined by volumetric method in malignant pleural mesothelioma and its effect on determination to survival Source: International Congress 2018 – Clinical management of pleural malignancies, including mesothelioma Year: 2018
Possibilities of reconstruction during pleuropneumonectomy with resection of pericardium and diaphragm in patients with malignant pleural mesothelioma Source: Eur Respir J 2006; 28: Suppl. 50, 719s Year: 2006
Chemotherapy for treatment of malignant pleural mesothelioma Source: Eur Respir J 2004; 24: Suppl. 48, 526s Year: 2004
Bevacizumab-targeted therapy for malignant pleural mesothelioma Source: International Congress 2017 – Malignant pleural effusion management in 2017: a review of recent RCTs Year: 2017
Salvage lung resection for local recurrence after stereotactic body radiotherapy for primary and metastatic lung cancers Source: Annual Congress 2011 - General thoracic surgery I Year: 2011
Malignant pleural mesothelioma (MPM): clinical presentation, complications and survival Source: Eur Respir J 2002; 20: Suppl. 38, 272s Year: 2002
Pleurectomy, decortication and hyperthermic chemotheraphy in malignant pleural mesothelioma, a single institution experience Source: International Congress 2017 – General thoracic surgery Year: 2017
Malignant pleural mesothelioma: new treatment modalities Source: Annual Congress 2005 - Clinical year in review Year: 2005
Multimodality therapy for malignant pleural mesothelioma Source: Eur Respir J 2004; 24: Suppl. 48, 526s Year: 2004
Evaluation of response to chemotherapy for malignant pleural mesothelioma and suggestion of a new method Source: Eur Respir J 2002; 20: Suppl. 38, 272s Year: 2002